Long-term secukinumab treatment among patients with hidradenitis suppurativa did not meet the time to loss of response endpoint at 104 weeks.

Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond to prior biologic therapy.

After private equity acquisition of United States hospitals, global measures of patient care experience worsened.

Providing surgery patients with an opioid disposal kit at the time of discharge increases their self-disposal rates.

States with strict abortion bans are losing residents, particularly younger people, which could have long-term economic implications.